Joni Ylostalo Institute for Regenerative Medicine, Texas A&M University Health Science Center, USA
2 protocols
HongLok Lung University of Hong Kong
61 protocols

Nicoletta Cordani University of Milano-Bicocca
25 protocols

Ningfei An University of Chicago
6 protocols

Shalini Low-Nam Purdue University
14 protocols

Thomas J. Bartosh
  • Assistant professor, Texas A&M University
Research focus
  • Stem cell
  • Adult Stem Cells
    Regenerative Medicine
    Cancer Biology
    Cancer Therapeutics
  • 2 Author merit


Ph.D., Cell Biology and Genetics, University of North Texas Health Science Center


Abbreviated Publication List
2 Protocols published
Mesenchymal Stem Cell (MSC) Aggregate Formation in vivo
Authors:  Thomas J. Bartosh and Joni H. Ylostalo, date: 07/20/2014, view: 10060, Q&A: 0
Human mesenchymal stem/progenitor cells (MSCs) isolated from various adult tissues show remarkable therapeutic potential and are being employed in clinical trials for the treatment of numerous diseases (Prockop et al., 2010). While routes ...
Macrophage Inflammatory Assay
Authors:  Thomas J. Bartosh and Joni H. Ylostalo, date: 07/20/2014, view: 26361, Q&A: 0
Macrophages represent a widely distributed and functionally diverse population of innate myeloid cells involved in inflammatory response to pathogens, tissue homeostasis and tissue repair (Murray and Wynn, 2011). Macrophages can be broadly grouped ...
4 Protocols reviewed
Analysis of Myosin II Minifilament Orientation at Epithelial Zonula Adherens
Authors:  Magdalene Michael, Xuan Liang and Guillermo A. Gomez, date: 12/05/2016, view: 6870, Q&A: 0
Non-muscle myosin II (NMII) form bipolar filaments, which bind F-actin to exert cellular contractility during physiological processes (Vicente-Manzanares et al., 2009). Using a combinatorial approach to fluorescently label both N- and ...
More >
Isolation and Culture of Human CD133+ Non-adherent Endothelial Forming Cells
Authors:  Michaelia P. Cockshell and Claudine S. Bonder, date: 04/05/2016, view: 9064, Q&A: 0
Circulating endothelial progenitor cells (EPCs) have been the focus of many clinical trials due to their roles in revascularisation following ischemic events such as acute myocardial infarction as well as their contribution to vascular repair during ...
More >
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.